title: Darbepoetin alfa in the treatment of anemia in renal transplant patients: a single-center report.
authors.forename: Wael
authors.initials: W
authors.lastname: El Haggan
authors.forename: Lydie
authors.initials: L
authors.lastname: Vallet
authors.forename: Bruno
authors.initials: B
authors.lastname: Hurault de Ligny
authors.forename: Myriam
authors.initials: M
authors.lastname: Pujo
authors.forename: Bénédicte
authors.initials: B
authors.lastname: Corne
authors.forename: Thierry
authors.initials: T
authors.lastname: Lobbedez
authors.forename: Béatrice
authors.initials: B
authors.lastname: Levaltier
authors.forename: Jean Philippe
authors.initials: JP
authors.lastname: Ryckelynck
mesh_terms: D000740:Anemia / Q000097:blood / Q000188:drug therapy* / Q000652:urine; D015415:Biomarkers / Q000097:blood; D001772:Blood Cell Count; D001794:Blood Pressure / Q000187:drug effects; D003404:Creatinine / Q000378:metabolism; D000068256:Darbepoetin alfa; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D006454:Hemoglobins / Q000032:analysis / Q000187:drug effects / Q000378:metabolism; D006801:Humans; D016030:Kidney Transplantation / Q000009:adverse effects*; D011183:Postoperative Complications / Q000188:drug therapy*; D011507:Proteinuria
chemical_list: D015415:Biomarkers; D006454:Hemoglobins; D004921:Erythropoietin; D000068256:Darbepoetin alfa; D003404:Creatinine